ASBP

Aspire Biopharma Holdings, Inc. Common Stock

21 hedge funds and large institutions have $18.2M invested in Aspire Biopharma Holdings, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
21
Holders Change
+7
Holders Change %
+50%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PC
1
Periscope Capital
Ontario, Canada
$2.18M +$542K +50,000 +33%
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$1.75M
AI
3
Arena Investors
New York
$1.75M
FTCM
4
Fir Tree Capital Management
New York
$1.71M +$925K +79,427 +118%
LP
5
LMR Partners
United Kingdom
$1.62M
ETH
6
Exos TFP Holdings
New York
$1.62M
AA
7
AQR Arbitrage
Connecticut
$1.62M
PSAMP
8
P. Schoenfeld Asset Management (PSAM)
New York
$1.44M -$182K -16,766 -11%
FTCM
9
First Trust Capital Management
Illinois
$1.39M +$1.39M +128,449 New
RCM
10
Radcliffe Capital Management
Pennsylvania
$1.1M -$523K -48,306 -32%
SCM
11
Shaolin Capital Management
Florida
$902K +$902K +83,251 New
WCMNY
12
Westchester Capital Management (New York)
New York
$420K +$420K +36,029 New
MSU
13
Mizuho Securities USA
New York
$376K +$376K +35,000 New
TI
14
Tidal Investments
Wisconsin
$130K +$130K +11,199 New
RCM
15
Robinson Capital Management
Michigan
$130K +$92.5K +8,015 +248%
SOA
16
Sea Otter Advisors
Florida
$15.7K +$15.7K +1,452 New
QL
17
Quarry LP
New York
$2.95K +$2.95K +272 New
UBS Group
18
UBS Group
Switzerland
$650 +$650 +60 New
EC
19
Elequin Capital
New York
$108 +$108 +10 New
TRCT
20
Tower Research Capital (TRC)
New York
$87 +$87 +8 New
KC
21
Kepos Capital
New York
-$1.59M -150,000 Closed
SIM
22
Sandia Investment Management
Massachusetts
-$1.56M -150,000 Closed
CS
23
Clear Street
New York
-$516K -49,526 Closed